INTERNATIONAL PATENT: ASTELLAS PHARMA INC., アステラス製薬株式会社 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR TREATING SPINAL CORD INJURY AND METHOD FOR PRODUCING NON-HUMAN PRIMATE ANIMAL MODEL FOR SPINAL CORD INJURY"

GENEVA, July 9 -- ASTELLAS PHARMA INC. (5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo1038411), アステラス製薬株式会社 (東京都中央区日本橋本町二丁目５番１号) filed a patent application (PCT/JP2024/046150) for "PHARMACEUTICAL COMPOSITION FOR TREATING SPINAL CORD INJURY AND METHOD FOR PRODUCING NON-HUMAN PRIMATE ANIMAL MODEL FOR SPINAL CORD INJURY" on Dec 26, 2024. With publication no. WO/2025/143118, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IP...